Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion ...
Donald Trump says his big new AI initiative is a victory for America. Guess who the real winner is.
Retro Biosciences is raising $1 billion, with the ultimate goal of using its customized AI to extend human lifespan by 10 ...
We recently published a list of 10 AI News You Should Definitely Take a Look At. In this article, we are going to take a look ...